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Trace elements and physical activity in children and adolescents
with depression
M. Metin DONMA1, Orkide DONMA2

Abstract: Depression is a common mental health problem among adolescents. Depressive symptoms are also important
and may appear even during the preschool period. Physical activity, which may improve some mental health problems,
is inversely associated with depression. Due to the presence of some clinical evidence about the relation between the use
of antidepressants and suicide, there is a need for supportive agents during antidepressant therapy. Within this context,
essential trace elements gain importance for further consideration. Protection of the developing brain from the negative
effects of iron deficiency is important because of iron deficiency’s association with poor mental development. Reactions
between copper and serotonin may contribute to the development of depression because copper may cause alterations
in dopamine and norepinephrine levels. Some links between zinc deficiency and depression-like behavior have been
noted. The antidepressant-like activity of zinc involves interaction with the serotonergic system. Selenium
supplementation significantly improves individuals’ mood scores. Low selenium status is associated with depression and
anemia, which may lead to poor mental development. The influence of physical activity on trace elements should also
be considered. The possible associations between members of neurotransmitter systems and metals as well as physical
activity are reviewed here in relation to depression in the youth population. Elevated or reduced levels of metals may be
indicators of depression. Intervention toward normalization of the profile of essential trace elements may prevent the
development of depression and support the effects of therapy in depressive individuals.
Key words: Child, adolescent, trace element, metal, depression, physical activity

Çocuklarda ve genç erişkinlerde görülen depresyonda eser elementler ve fiziksel
aktivite
Özet: Depresyon genç erişkinler arasında yaygın görülen bir akıl sağlığı problemidir. Depresyon belirtileri okul öncesi
dönemde bile ortaya çıkabilir. Bazı akıl sağlığı problemleri üzerinde olumlu etkisi gözlenen fiziksel aktivite depresyon ile
ters ilişkilidir. Antidepressan kullanımı ve intihar arasındaki ilişki ile ilgili bazı klinik delillere bağlı olarak, antidepressan
tedavi sırasında destekleyici ajanlara gereksinim duyulmaktadır. Bu bağlamda, esansiyel eser elementler ileriye yönelik
araştırmalar için önem kazanmaktadır. Gelişmekte olan beyinin, yetersiz zekâ gelişimi ile olan ilişkisi nedeniyle demir
eksikliğinin olumsuz etkilerinden korunması, demir düzeyinin önemine işaret etmektedir. Bakır, dopamin ve
norepinefrin düzeylerinde değişikliklere neden olabildiğinden, bakır ve serotonin arasındaki reaksiyonlar depresyonun
gelişmesine katkıda bulunabilir. Çinko eksikliği ile depresyon benzeri davranışlar arasında bazı bağlantılar bildirilmiştir.
Çinkonun antidepresan benzeri aktivitesi serotonerjik sistem ile olan etkileşimi içermektedir. Selenyum desteği, bireylerin
ruhsal durumlarını önemli ölçüde iyileştirmektedir. Düşük selenyum düzeyi, depresyon ve yetersiz zihinsel gelişmeye yol
açabilen anemi ile birliktelik göstermektedir. Fiziksel aktivitenin eser elementler üzerine olan etkisi de göz önüne alınması
gereken bir husustur. Bu makalede, fiziksel aktivite ile metaller ve nörotransmitter sistemlere ilişkin parametreler
arasındaki olası ilişkiler, çocuk ve gençlerde görülen depresyonla bağlantılı biçimde gözden geçirilmiştir. Artmış ya da
azalmış metal düzeyleri depresyon göstergeleri olabilirler. Esansiyel eser element profilinin normalleştirilmesine yönelik
girişimler, depresyonun gelişmesini önleyebilir ve depresyonlu bireylerde tedavinin etkisini destekleyebilir.
Anahtar sözcükler: Çocuk, genç erişkin, eser element, metal, depresyon, fiziksel aktivite
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Introduction
Depression is a disease that frequently occurs in
childhood and adolescence. Depression is present in
about 1% of children and 5% of adolescents. Suicidal
behavior, which is a common cause of death,
especially in young people, is closely associated with
depression (1-3).
Biological
markers
of
serotonin
(5hydroxytryptamine, 5-HT) are decreased in
depression. Pharmacotherapy is based on the
enhancement of serotonergic and/or noradrenergic
neurotransmission, either by inhibiting the
degradation of monoamines by monoamine oxidase
(MAO) inhibitors or by blocking their uptake back
into the synaptic cleft by selective serotonin reuptake
inhibitors (SSRIs), selective norepinephrine reuptake
inhibitors (SNRIs), or tricyclic antidepressants (TCA)
(4,5). SSRIs and SNRIs bind the monoamine
transporter proteins with high selectivity and affinity,
block the neurotransmitter translocation process, and
lead to an increase in synaptic monoamines (6,7).
It is generally accepted that physical activity (PA)
is associated with children’s mental health as well as
their physical and psychological well-being (8,9).
Exercise was also found to be associated with
prevention of depressive disorders (8-14).
Considering that essential metals are multi-faceted
with their beneficial (15) and harmful (16) properties,
it is reasonable to suggest that they may also influence
the neurotransmitter systems. In this article, the
possible associations between the members of this
system and metals as well as PA are reviewed in
relation to depression in the youth population.
Child and Adolescent Depression
Depression continues to be the most common
mental health problem among adolescents and
requires psychological support (17). Depression can
also arise during the preschool period. Recent reports
have pointed out depression before the age of 6, and
the symptoms may arise as early as age 3 due to shame
and guilt (18,19). Early life stress predisposes
individuals to the development of subsequent
psychiatric illness, including major depressive
disorder. Lower brain 5-HT transporter binding
potentials (5-HTT BPP) in depressed subjects have
recently been shown to be associated with reported
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histories of childhood abuse (20). Depressive
symptoms in children may appear in conjunction
with problematic mother-child interactions. For
example, pain, which may be associated with
depressive symptoms, as well as some alterations in
metal and neurotransmitter metabolisms in children
and adolescents with headaches, may cause parentadolescent conflict (21,22). In a similar manner,
maternal depression is associated with toddler
behavioral problems, which may persist into late
childhood (23). Maternal depression is also a risk
factor for depressive and anxiety symptoms, which
increase in frequency over the first 5 years of life.
Effects of Physical Activity on Mental Health
and Depression among Children and Adolescents
Effects of Physical Activity on Mental WellBeing
The number of studies that find PA beneficial for
child and adolescent mental health status is increasing
(8,9,11,24-28). The literature on the relation between
PA and children’s health requires future investigation.
PA may be a critical factor affecting children’s
immediate and long-term health. The need to
promote exercise and lifestyle, including PA, is
introduced as a means of enhancing children’s positive
well-being (29). Significant associations between
exercise and positive mood were observed (30).
Significant increases in positive emotions and
decreases in negative emotions prior to and after
exercise and higher levels of pride with natural
(outdoors in a natural environment) rather than
laboratory (indoors on a laboratory treadmill)
running for 5 km were detected (31). Children who
met recommended levels for PA had fewer emotional
problems 1 year later (32). Weekly hours of PA at the
ages of 15-16 years influenced mental health
positively 3 years later in boys (33). Physical activity
for children is also important for promoting good
sleep (34). The impact of sleep on mental health
during adolescence has been investigated and
adolescent sleep chronobiology was found to be
associated with psychological well-being (35).
Effects of Physical Activity on Depression
PA may have physiologic effects on depression due
to an increased release of β-endorphins and brain
neurotransmitters such as 5-HT, dopamine (DA), and
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norepinephrine (NE) (36). Fitness training was
associated with positive emotional and behavioral
responses, in addition to reduction of depressive
symptoms (14). A 9-week exercise intervention plan
(20-30 min, 3 days per week) caused a reduction in
the symptoms of depression (13). Adolescents who
engaged in regular PA were characterized by lower
anxiety-depression scores and displayed less social
and behavioral inhibition than their less active
counterparts (8). PA time was inversely associated
with depression in adolescents (11,24,37). Compared
to the inactive group (0-0.9 h of PA time per week),
active students who spent at least 1 h per week on PA
were at significantly lower (<30%) risk of being
depressive, and their odds of being depressive
decreased from 63% to 58% and 53% as PA time
increased from 1-7 h/week, 8-14 h/week, and 15+
h/week, respectively (37). For example, in children
assigned to an aerobic intensity PA program,
significantly less depression was reported (25).
Similarly, a beneficial effect of PA on feelings of
sadness and suicidal behaviors was observed (26).
In another study, exercise diminished the clinical
symptoms of patients with psychiatric disorders.
Especially in the case of patients with depression,
endurance exercise significantly improved their mood
(27). Upon examination of the relation between
depression and PA, a significant reduction in
depression was found among preadolescents enrolled
in after-school exercise programs. Findings supported
social, cognitive, and self-efficacy theories as well as
the association between PA and improved mental
health in preadolescents (28).
The relation between PA and child/adolescent
mental health status is improving. Involvement of
oxygen with respect to oxidative stress, particularly in
aerobic exercises and its association with metals,
makes the topic more complicated. Evaluation of the
topic as a whole will lead to a solution for the problem.
Life Course from Depression to Suicide
The Relation between Depression and Suicide
Psychotic disorders and psychotic-like experiences
may increase the risk of suicidal problems among
adolescents (38,39). Major depressive disorder causes
significant morbidity, affecting people’s ability to
work, function in relationships, and engage in social

activities, and also increases the risk of suicidal
ideation, attempted suicide, and death by completed
suicide (40).
Long durations of depression (>13 months),
anhedonia, feelings of worthlessness, comorbid
anxiety, previous suicidal ideation, and the use of
professional care are important determinants of
suicidality among depressed patients (39,41).
Repetition of suicidal behavior is associated with high
anxiety, severe depression, and other psychiatric
symptoms, and is increased in young patients (42).
Suicide is among the 3 leading causes of death for
adolescents in the world, and suicide rates are rising
faster among teenagers than for other age groups.
Since depression can lead to many adverse results,
including academic dysfunction, increased arguments
with family members, and suicide, a major issue in
suicide prevention is the screening of all children and
adolescents for depression and other factors that may
trigger suicide in adolescence (43).
Considerations and Possible Risks Regarding
the Use of Antidepressant Medications in Children
and Adolescents
Maternal depression increases the risk of
emotional and behavioral problems in children (44).
Adolescent depression is also a serious illness
associated with substantial morbidity and mortality
(1). SSRIs are the most commonly used treatment for
adolescent depression (2).
Today the safety of the newer antidepressant drugs,
including SSRIs, is still under review. The important
question is whether SSRIs increase the risk of suicidal
behavior in depressed children (1). Many
antidepressants are excreted in breast milk (45,46). No
psychotropic drug is free of potential negative effects.
Fluoxetine is the only SSRI currently approved for
pediatric use; however, some cautionary remarks have
been made about it (45).
Effects of treatment among children and
adolescents need to be understood better, because
data indicate that age is a modifier of treatment effects
(47). Treatment with SSRIs does not increase the risk
of suicide in adults; however, in children, adolescents,
and young adults being treated with antidepressants,
there is a tendency of a rise in the risk of attempted
suicide (48,49).
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Clinical Evidence on Antidepressant-Induced
Suicidality
Suicidal thoughts and suicide attempts have been
higher among depressed children and adolescents
receiving antidepressants than among those receiving
placebos in controlled clinical trials (45). These
documented links between the use of antidepressants
and suicide are very important. The Federal Drug
Administration’s meta-analysis suggests that
“Antidepressant medicines may increase suicidal
thoughts or actions in some children, teenagers and
young adults when the medicine is first started”
(50,51). Findings of a relation between suicidality and
completed suicide point out the possibility of an
increased risk of suicidality due to antidepressant
drugs and the limited knowledge about
antidepressants, particularly in terms of their
pediatric use (52).
The relation between exposure to SSRIs and the
risk of suicide is influenced by age. Among
adolescents, use of antidepressants is associated with
a significantly increased risk of suicidal adverse events
(53,54). Suicidal ingestions of SSRIs, SNRIs, and other
antidepressants peaked in teens (55). The risk of
suicidal thoughts and behaviors in the treatment of
depressive children and adolescents with SSRIs and
SNRIs is slightly but significantly elevated (56). In
another study, an overall increased risk of suicidal
ideation was reported during pediatric antidepressant
treatment, as compared with placebo treatment (57).
There are also studies reporting that treatment of
depressed youth with antidepressants, including
SSRIs, carries a small increased risk of suicidality
(47,58). Antidepressants should be used cautiously in
adolescents who are under the threat of increased risk
for suicide (54,59).
Present Situation of
Psychopharmacotherapeutic Interventions for
Suicidal Behaviors
Children appear to be at a higher risk than adults
for drug-induced adverse effects. Both the needs of
children being treated and the seriousness of the
adverse effects call for large-scale clinical studies to
understand the mechanisms underlying toxicities and
to develop effective preventive and treatment
strategies (60). Upon analysis of the Treatment for
Adolescents with Depression Study (TADS) database,
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the severity of self-rated suicidal ideation and
depressive symptoms predicted the emergence of
suicidality during treatment. Depressed adolescents
who manifest suicidal ideation at the beginning of the
treatment are at increased risk of suicidal events
during treatment. The risk of suicidal events does not
decrease after the first month of treatment, suggesting
the need for maintenance of careful clinical
monitoring during treatment (61). The clinical trials
on adolescent depression provide information on the
benefits and limitations of current treatments (62).
Nutritional Aspects
Since there are great controversies related to the
usage of antidepressant medications in children and
adolescents, it is reasonable to search for remedies that
may be associated with some related parameters.
Nutrition gains importance when depression is
considered. Dietary metals are closely involved with
behavior and cognition. The controversial effects of
phytochemicals as well as toxic metals should also be
considered (63-66). Due to the close relationship
between depressive disorders and suicidality, and the
possible effects of dietary metals on people’s behavior
and cognition, a discussion about trace metals and
depression would be helpful.
Trace Elements-Induced Changes Affecting
Neurotransmitter System Parameters
The metals deserve attention in the field of
neurotransmitters and related metabolisms. It is
worthwhile to investigate the association between
metals and depression because elements play vital
roles in human metabolism (67). A vast amount of
information in the scientific literature on trace
elements aims to establish some important medical
and diagnostic links between the metal
concentrations and various diseases. Therefore, the
possible relations among trace elements, physical
activity, and neurotransmitters in the depression of
children and adolescents are reviewed.
Iron
Iron (Fe) needs to be administered to augment
physical capacity during exercise; however, during
athletic activity, Fe may damage tissues by catalyzing
the conversion of hydrogen peroxide to free radical
ions. Both Fe deficiency and excess are deleterious
(68).
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Fe, an essential metal indispensable for human
health in trace amounts, is extremely dangerous and
harmful in excess amounts. Free Fe can cause
considerable oxidative damage through the Fenton
reaction. Tryptophan, an essential amino acid serving
as the precursor for serotonin, has the special ability
to bind Fe. Tryptophan can form some carcinogenic
metabolites that are only toxic when combined with
Fe (69). Fe may induce cancer through oxidative
damage and the formation of complexes with
tryptophan. Fe, by reacting with tryptophan, can
reduce the production of serotonin and melatonin
(70,71), parameters associated with depression.
The Fe status of the mother determines the child’s
Fe status. Iron deficiency (ID) during late fetal and
early neonatal life is a risk to the developing brain,
manifesting with alterations in brain function during
the newborn period. It is important to protect the
developing brain from the negative effects of ID
during infancy because of ID’s association with poor
mental development (72-74). An association between
depression and decreased ferritin levels detected
among medical students may point to low Fe status as
an indicator of depression (75). Fe deficiency is an
important health problem in children, women of
child-bearing age, and pregnant women, in both
developed and developing countries. Fe excess also
threatens the health of young individuals. Therefore,
interactions of Fe with many essential and toxic
metals are worth mentioning.
Copper
Some members of antioxidative systems (Cu/ZnSOD, Cu-thioneine) and enzymes such as tyrosinase,
tyrosine hydroxylase, and dopamine-β-hydroxylase
require copper (Cu) for their optimum activities.
Therefore, copper deficiency may lead to reduced
catecholamine synthesis.
When present in high concentrations, Cu can
cause some problems in the brain. It can impair zinc
(Zn) uptake. Free radicals are associated with low
Cu/Zn-SOD activity. Therefore, Cu, which favors free
radical formation reactions in its excess amount, can
devastate the brain. Copper, being the cofactor for
tyrosinase, causes increased synthesis of DA, which
inhibits the tryptophan hydroxylase required for 5HT synthesis (70,71).

Serotonin, an important neurotransmitter in the
brain and spinal cord, is involved in the control of
sleep, consciousness, aggression, and mood. It is also
implicated in disturbances such as anxiety and
depression. In the presence of Cu, serotonin is capable
of causing strand cleavage in DNA and cell death
through an oxidative mechanism. Serotonin reduces
Cu2+ to Cu1+. The latter participates in the generation
of hydroxyl radicals. Serotonin is able to bind DNA
and Cu ions. Since Cu is an essential component of
chromatin, the formation of a serotonin-Cu-DNA
complex is possible (76,77).
Copper is involved in some physiological systems,
such as conversion of DA to NE, signal transduction,
intracellular calcium mobilization, and energy
production via cytochrome c oxidase, which
participate in the development of postpartum
depression (PPD). There may be an association
between elevated Cu levels and PPD. Elevated Cu
levels may cause alterations in DA and NE levels in
women with PPD. PPD, which occurs during the
post-natal period, may be associated with suicidal and
homicidal behavior in severe cases. Depression in
mothers increases the risk of emotional and
behavioral problems in children. Maternal depression
and adjustment problems of the child are common
health problems and impose significant burdens on
society (44,78).
Cu homeostasis is essential during PA and sports
(79). During intense physical exercise, superoxide
dismutase (SOD) activity is increased, favoring the
adaptation of Cu metal (80-82). Since Cu is a doubleedged sword, the delicate balance between its
deficiency and excess states is extremely critical; its
concentration must be evaluated carefully so that a
deficiency is corrected by supplementation or an
excess is removed through chelation. The
contradictory results reported in athletes complicate
the interpretation of the effect of PA on depression
from the point of view of Cu.
Zinc
Zn is essential for physical growth and
development. Fetal neurobehavioral development
improves during pregnancy when Zn is added to Fe
and folate supplements (74).
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Zn acts as a neuromodulator at excitatory synapses
and plays a role in the stress response and in the
functionality of Zn-dependent enzymes, contributing
to the brain’s compensatory capacity. The mechanisms
that modulate the free Zn pool are pivotal for brain
health and performance (83). Zinc can cause
deficiencies or imbalances of other metals.
Absorption of Fe and Cu from the intestine is limited
by Zn (74).
Many contradictory results were observed about
the association between Zn and PA. Zn as a
component of SOD protects against the formation of
reactive oxygen species (ROS). Athletes of longdistance, high-impact aerobic modalities had higher
indices of antioxidant protection, e.g., erythrocyte Zn,
SOD, and metallothionein, than those of shortdistance, low-impact modalities. This suggests the
adaptation of the antioxidative defensive mechanisms
to PA and indicates that an adequate Zn status is
important for the effectiveness of antioxidant
mechanisms in response to intense exercise
(68,81,84).
Severe Zn deficiency in pregnancy adversely
affects mental development and behavior. Zn may
regulate 5-HT and NE content in the brain by
inhibiting MAO-A activity. A link between Zn
deficiency and mood disorders such as depressionlike behavior has been pointed out (85-87). A
relationship between depression and low Zn was
noted in cases of PPD (88).
Although an insignificant relation between Zn
status and depression was reported among
thalassemia patients in a single study (89), Zn plays a
significant role in the improvement of depression
(90). Zn may be a sensitive and specific marker of
depression because Zn exhibits antidepressant-like
activity in models of depression, and also has an effect
on the N-methyl-D-aspartate (NMDA)/glutamate
pathway in suicide victims (91). The antidepressantlike activity of Zn observed in the forced swim test
involves interaction with the serotonergic system (92)
and is correlated with an alteration in the function of
the NMDA receptor (93). Zn supplementation
enhances the efficacy of pharmacotherapy in affective
disorders because of its potential clinical
antidepressant activity (94,95). Zn is involved in the
regulation of brain-derived neurotrophic factor
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expression, which plays a key role in the
pathophysiology and treatment of depression (96).
Recent reports on Zn augmentation therapy have
introduced the potential use of Zn in combination
with pharmacologic treatment for the strongest effect
in treating mental health problems (97,98). These
findings suggest the use of Zn as a potential
antidepressant agent.
Zn supplementation is required in the areas where
Zn deficiency is common. However, Helicobacter
pylori (HP), prevalent in developing countries and the
cause of gastric cancer as well as HP infection,
requires Zn for growth and virulence. Aflatoxin (AF),
a common food contaminant, causes impaired growth
and immune system disorders in such areas. Zn is also
needed for the enhancement of Aspergillus flavus
biomass and AF production. These factors should also
be considered during interventions related to Zn
supplementation performed for the improvement of
mental health status in children.
Selenium
Selenium (Se), another essential element,
possesses antioxidant functions as an integral
component of glutathione peroxidase (GSH-Px).
Selenoproteins protect neurons. Low Se status is
associated with depression. Se toxicity is also
important. Increased exposure to Se causes nervous
system disorders in humans. Alterations related to DA
metabolites caused by inorganic Se, which is more
neurotoxic than organic Se, suggest a Se-specific
increased neural activity of dopaminergic pathways
(99-101).
Se is an important modulator of moods.
Experimental studies reported that individuals fed
with marginally low Se diets displayed more
symptoms of depression than individuals fed with
higher Se diets (102,103). As compared to the placebo,
Se supplementation significantly improves
individuals’ mood scores (104).
Low Se status is associated with anemia (105),
which may lead to poor mental development among
school children. Alcohol consumption among
adolescents may lead to a deficiency of
micronutrients, including Se. The harmful effects of
alcohol on mood, behavior, and cognition may be
partly mediated by biological changes related to Se
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deficiency. Preventive or therapeutic compounds that
contain Se may be beneficial for psychiatric and
neurological conditions (100,101).
During PA, oxidative stress due to excessive
oxygen consumption is compensated by higher levels
of free radical scavengers and by an increase in the
activities of antioxidant enzymes (68,82,106-108). Few
results are available concerning Se concentration
during or following PA, and the levels of GSHPx
reported in athletes are divergent (109,110). It is
reported that athletes are generally not affected by Se
deficiency. Therefore, Se supplementation should be
carried out with particularly great care in athletes
because of the 5-HT reducing effect of high Se.
Concluding remarks

infection are also involved in this discussion. Aside
from their association with increased ROS formation,
one should also consider the relations between
infectious agents and metals (112,113). If the facts that
Zn is essential for the growth and virulence of HP and
is also a stimulator of Aspergillus flavus growth and
AF production are underestimated, then it may be
difficult to achieve success in supplementation
programs organized to overcome Zn deficiency,
which are important in preventing mental health
disorders such as depression and schizophrenia
among young people. In trying to improve the mental
health status of the population, an increase in high AF
exposure or high HP prevalence may occur. This is
particularly important for the pediatric population
and pregnant women.

The concept of trace elements covers a broad area
and their spectrum is extremely wide. Toxic metal
excess and/or essential metal deficiency-induced
increases in MAO activity are noteworthy (85,86,111).
Greater attention should be paid to nutritional factors
in psychiatry. Consideration of the multiple aspects
of trace element actions on the metabolisms of 5-HT,
DA, and NE in combination with the current therapy
protocols could offer a more effective treatment for
depressed patients and suicidality. Trace elements,
present in tiny amounts, occur at the crossroads of the
metabolic
pathways,
including
those
of
neurotransmitters. They are also closely related to
radical formations, and thus to oxidative stress, which
is known to be involved in the pathogenesis of many
clinical disorders.

Elevated or reduced levels of metals may be
indicators of depression. Interventions toward
normalization of the profile of essential trace elements
may prevent the development of depression and exert
therapeutic effects in depressive individuals.

Besides nutrition, the parameters that may
possibly be related to metal metabolism are quite
important for mental health. Infections such as HP

This work was supported by the Research Fund of
the University of İstanbul. Project No: UDP-576/
07072005.

The evidence has demonstrated that within the
scope of integrated metabolic pathways, SSRIs and
SNRIs are not alone in the course of treatment.
Consideration of metals along with oxidative stress
markers may be suggested as a key to depression and
its potential ultimate result, suicide, and will set the
stage for a new era of more effective therapy to reduce
mortality from suicide in depressed subjects.
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